Skip to main content
ConductScienceScienceDex

Thomas Argentieri

NIH Rank #4075
Unclaimed recordClaim profile
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 78331236Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2025 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2026

Linked Award Amount
$1.5M
Full award amounts, FY2026
Award Records
1
Records listing this PI
Award-Linked Rank
#4,075
By linked amount among FY2026 PIs
Earliest Year Loaded
2025
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Thomas Argentieri. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Thomas Argentieri as a PI. Multi-PI records show the full award amount for context.

  • 5R44HL160338-03R44
    Minimizing myocardial damage and loss of cardiac function post myocardial infarction using Targeted PKC inhibitors 002 and 004.
    Young Therapeutics, Llc
    $1.5M
    award amount

Award organization

Organizations that administered FY2026 awards listing Thomas Argentieri as a PI.

FY2026 award administered by Young Therapeutics, Llc (PA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2025
    First NIH Award
    Young Therapeutics, Llc
  2. 2025
    $500K Cumulative Funding
  3. 2025
    $1M Cumulative Funding
  4. 2026
    $2M Cumulative Funding
  5. 2026
    Entered Top 50% Nationally
    Ranked #4075
  6. 2026
    Entered Top 25% Nationally
    Ranked #4075

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Thomas Argentieri.

Lindon H Young
Young Therapeutics, Llc
2
shared awards

Explore further

Find collaborators for Thomas Argentieri

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →